🇺🇸 FDA
Patent

US 7074893

Methods and compositions for the treatment of diseases associated with signal transduction aberrations

granted A61KA61K38/08A61K38/10

Quick answer

US patent 7074893 (Methods and compositions for the treatment of diseases associated with signal transduction aberrations) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/08, A61K38/10